Covidien plc to Report Fourth-Quarter Results on November 17, 2009

Covidien plc (NYSE: COV) will report fourth-quarter results before trading begins on November 17, 2009. The Company will hold a conference call for investors at 8:30 a.m. ET. The call can be accessed in the following ways:
At Covidien’s website: http://investor.covidien.com
By telephone: For both “listen-only” participants and those participants who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 866-713-8310. For participants outside the U.S., the dial-in number is 617-597-5308. The access code for all callers is 91064338.
Through an audio replay: A replay of the conference call will be available beginning at 11:30 a.m. on November 17, 2009, and ending at 5:00 p.m. on November 24, 2009. The dial-in number for U.S. participants is 888-286-8010. For participants outside the U.S., the replay dial-in number is 617-801-6888. The replay access code for all callers is 58107629.

ABOUT COVIDIEN

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2008 revenue of $10 billion, Covidien has more than 41,000 employees worldwide in 59 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.

CONTACTS :

Covidien plc
Eric Kraus, 508-261-8305
Senior Vice President
Corporate Communications
eric.kraus {at} covidien(.)com
or
Coleman Lannum, CFA, 508-452-4343
Vice President
Investor Relations
cole.lannum {at} covidien(.)com
or
Bruce Farmer, 508-452-4372
Vice President
Public Relations
bruce.farmer {at} covidien(.)com
or
Brian Nameth, 508-452-4363
Director
Investor Relations
brian.nameth {at} covidien(.)com